At the news
? NEUTRALIMPACT 2/10 144 filed Nov 13, 2026 at 16:05 ET
John Cox, an officer of Dyne Therapeutics, filed a Form 144 notice of intent to sell 5,513 shares of common stock, with an estimated aggregate market value of approximately $92,751 based on a price of $16.82 per share. The sale is related to the vesting of restricted stock units and represents a routine insider transaction for tax or diversification purposes.
- Reporting person: John Cox, an officer of Dyne Therapeutics
- Shares to be sold: 5,513 shares of common stock
- Estimated aggregate market value: $92,751 (based on $16.82 per share)
- Sale intended on or about 11/13/2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access